Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis

Background: Recurrent respiratory papillomatosis (RRP) is a rare disorder characterized by the generation of papillomas of the aerodigestive tract, usually associated with human papilloma virus (HPV) subtypes 6, 11. INO-3106 is a DNA plasmid-based immunotherapy targeting E6 and E7 proteins of HPV6,...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Vaccines (Basel)
Prif Awduron: Aggarwal, Charu, Cohen, Roger B., Morrow, Matthew P., Kraynyak, Kimberly A., Sylvester, Albert J., Cheung, Jocelyn, Dickerson, Kelsie, Schulten, Veronique, Knoblock, Dawson, Gillespie, Elisabeth, Bauml, Joshua M., Yan, Jian, Diehl, Malissa, Boyer, Jean, Dallas, Michael, Kim, J. Joseph, Weiner, David B., Skolnik, Jeffrey M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7158680/
https://ncbi.nlm.nih.gov/pubmed/32013270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8010056
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg